£300K
SleepCogni has secured £300k in a bridging round to support international expansion and regulatory approvals.

The bridging round extends the company runway ahead of a larger raise planned for 2025.
"I am delighted to strengthen our commercial team and announce this additional funding. The continued support from our investors is a testament to their confidence in our mission and the team’s ability to deliver. With a well-rounded executive team featuring experience from global leaders in pharmaceuticals like Teva, healthcare insurance giants such as Aetna, and consumer retail leaders like Apple, we are well-positioned to drive the business forward."

